FuranodieneCAS# 19912-61-9 |
- Isofuranodiene
Catalog No.:BCN5781
CAS No.:57566-47-9
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 19912-61-9 | SDF | Download SDF |
PubChem ID | 636458 | Appearance | Powder |
Formula | C15H20O | M.Wt | 216.15 |
Type of Compound | Sesquiterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (5E,9E)-3,6,10-trimethyl-4,7,8,11-tetrahydrocyclodeca[b]furan | ||
SMILES | CC1=CCC2=C(CC(=CCC1)C)OC=C2C | ||
Standard InChIKey | VMDXHYHOJPKFEK-IAVOFVOCSA-N | ||
Standard InChI | InChI=1S/C15H20O/c1-11-5-4-6-12(2)9-15-14(8-7-11)13(3)10-16-15/h6-7,10H,4-5,8-9H2,1-3H3/b11-7+,12-6+ | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Furanodiene suppresses breast cancer cell growth both in vitro and in vivo and could be a new lead compound for breast cancer chemotherapy. 2. Furanodiene has anti-inflammatory activity, it suppressed the TPA-induced inflammation of mouse ears by 75% at a dose of 1.0 micromol. 3. Furanodiene presents synergistic anti-proliferative activity with paclitaxel via altering cell cycle and integrin signaling in 95-D lung cancer cells. 4. Furanodiene has antioxidant activity. 5. Furanodiene is active against gram-positive bacteria and Candida albicans. |
Targets | CDK | PARP | Caspase | Akt | AChR | BChE | c-Myc | Immunology & Inflammation related | Antifection |
Furanodiene Dilution Calculator
Furanodiene Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.6264 mL | 23.1321 mL | 46.2642 mL | 92.5283 mL | 115.6604 mL |
5 mM | 0.9253 mL | 4.6264 mL | 9.2528 mL | 18.5057 mL | 23.1321 mL |
10 mM | 0.4626 mL | 2.3132 mL | 4.6264 mL | 9.2528 mL | 11.566 mL |
50 mM | 0.0925 mL | 0.4626 mL | 0.9253 mL | 1.8506 mL | 2.3132 mL |
100 mM | 0.0463 mL | 0.2313 mL | 0.4626 mL | 0.9253 mL | 1.1566 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- T 98475
Catalog No.:BCC7395
CAS No.:199119-18-1
- Balaglitazone
Catalog No.:BCC1395
CAS No.:199113-98-9
- H-Phe(4-Me)-OH
Catalog No.:BCC3270
CAS No.:1991-87-3
- Maackiain
Catalog No.:BCN1236
CAS No.:19908-48-6
- Bakkenolide A
Catalog No.:BCN5402
CAS No.:19906-72-0
- Dihydromethysticin
Catalog No.:BCN2476
CAS No.:19902-91-1
- Syringaresinol diacetate
Catalog No.:BCN4874
CAS No.:1990-77-8
- Kaempferol 3-O-beta-sophoroside
Catalog No.:BCN3336
CAS No.:19895-95-5
- 29-Nor-20-oxolupeol
Catalog No.:BCN6678
CAS No.:19891-85-1
- Jaborosalactone D
Catalog No.:BCN7946
CAS No.:19891-82-8
- Nagilactone B
Catalog No.:BCN4049
CAS No.:19891-51-1
- Atazanavir
Catalog No.:BCC3622
CAS No.:198904-31-3
- Chamigrenal
Catalog No.:BCN7847
CAS No.:19912-84-6
- Futoenone
Catalog No.:BCN6408
CAS No.:19913-01-0
- Enniatin B1
Catalog No.:BCN4853
CAS No.:19914-20-6
- Boc-D-N-Me-Ala-OH
Catalog No.:BCC3211
CAS No.:19914-38-6
- O6-Benzylguanine
Catalog No.:BCC6485
CAS No.:19916-73-5
- Dehydroglyasperin C
Catalog No.:BCN6790
CAS No.:199331-35-6
- Glyurallin A
Catalog No.:BCN7538
CAS No.:199331-36-7
- Crocatone
Catalog No.:BCN3532
CAS No.:19937-86-1
- Kolavenol
Catalog No.:BCN4680
CAS No.:19941-83-4
- Gymnestrogenin
Catalog No.:BCN7846
CAS No.:19942-02-0
- 3-Epicabraleadiol
Catalog No.:BCN4875
CAS No.:19942-04-2
- Y-33075
Catalog No.:BCC2064
CAS No.:199433-58-4
Cytotoxicity and inhibition of leukemic cell proliferation by sesquiterpenes from rhizomes of Mah-Lueang (Curcuma cf. viridiflora Roxb.).[Pubmed:29274817]
Bioorg Med Chem Lett. 2017 Dec 13. pii: S0960-894X(17)31189-7.
Curcuma cf. viridiflora Roxb., also known as Mah-Lueang in Thai, belongs to the Zingiberaceae family and is grown from rhizomes. The rhizome of the plant has been used for medicinal purposes, in particular, to treat paralysis in Thai traditional medicine. However, no biologically active compounds have been reported from Mah-Lueang yet. In this study, natural compounds were isolated from Mah-Lueang and structurally determined by spectroscopic methods, including electrospray ionization mass spectrometry and nuclear magnetic resonance. The four isolated compounds were identified as Furanodiene (1), dehydrocurdione (2), germacrone-4,5-epoxide (3), and zedoarondiol (4). These sesquiterpenes were investigated for antileukemic activities against KG1a and Molt4 cells. Leukemic cell proliferation is regulated by the Wilms' tumor 1 (WT1) transcription factor. Compound 1 showed the strongest cytotoxicity against both KG1a and Molt4 cells. Noncytotoxic concentrations (20% inhibitory concentration values) of all compounds were able to decrease the WT1 protein expression and total cell numbers in both cell lines. The four compounds showed good inhibitory activities for WT1 protein expression. Compounds 3 and 4 showed excellent antileukemic activities for both cell lines. In summary, four sesquiterpene compounds with antileukemic activities against the KG1a and Molt4 cell lines were identified in Mah-Lueang extracts.
Anti-inflammatory sesquiterpenes from Curcuma zedoaria.[Pubmed:16901812]
Nat Prod Res. 2006 Jun;20(7):680-5.
From the methanolic extract of the rhizome of Curcuma zedoaria, we isolated anti-inflammatory sesquiterpene Furanodiene (1) and furanodienone (2) along with new sesquiterpene compound 3 and known eight sesquiterpenes, zederone (4), curzerenone (5), curzeone (6), germacrone (7), 13-hydroxygermacrone (8), dehydrocurdione (9), curcumenone (10), and zedoaronediol (11). Their structures were elucidated on the basis of spectroscopic data. The anti-inflammatory effect of isolated components on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation of mouse ears were examined. Compounds 1 and 2 suppressed the TPA-induced inflammation of mouse ears by 75% and 53%, respectively, at a dose of 1.0 micromol. Their activities are comparable to that of indomethacin, the normally used anti-inflammatory agent.
Furanodiene, a natural product, inhibits breast cancer growth both in vitro and in vivo.[Pubmed:22854281]
Cell Physiol Biochem. 2012;30(3):778-90.
PURPOSE: Previous studies have reported that the Curcuma wenyujin Y.H. Chen et C. Ling extract, which has a high Furanodiene content, showed anti-cancer effects in breast cancer cells in vitro. The present study was designed to evaluate the in vitro and in vivo anti-cancer activity of Furanodiene. METHODS: The in vitro effects of Furanodiene were examined on two human breast cancer cell lines, MCF-7 and MDA-MB-231 cells. Assays of proliferation, LDH release, mitochondrial membrane potential (DeltaPsim), cell cycle distribution, apoptosis and relevant signaling pathways were performed. The in vivo effect was determined with MCF7 tumor xenograft model in nude mice. RESULTS: Furanodiene significantly inhibited the proliferation and increased the LDH release in both cell lines in a dose-dependent manner. DeltaPsim depolarization, chromatin condensation, and DNA fragmentation were also observed after Furanodiene treatment. Furanodiene dose-dependently induced cell cycle arrest at the G0/G1 phase. The protein expressions of p-cyclin D1, total cyclin D1, p-CDK2, total CDK2, p-Rb, total Rb, Bcl-xL, and Akt were significantly inhibited by Furanodiene, whereas the protein expressions of Bad and Bax, and the proteolytic cleavage of caspase-9, caspase-7, and poly-ADP-ribose polymerase (PARP) were dramatically increased. Furthermore, the z-VAD-fmk markedly reversed the Furanodiene-induced cell cytotoxicity, the proteolytic cleavage of caspase-9, and DNA fragmentation but did not affect the proteolytic cleavage of PARP, whereas the Akt inhibitor VIII increased the Furanodiene-induced cytotoxicity and PARP cleavage. In addition, Furanodiene dose-dependently suppressed the tumor growth in vivo, achieving 32% and 54% inhibition rates after intraperitoneal injection of 15 mg/kg and 30 mg/kg, respectively. CONCLUSIONS: Taken together, we concluded that Furanodiene suppresses breast cancer cell growth both in vitro and in vivo and could be a new lead compound for breast cancer chemotherapy.
Cholinesterase inhibitory activities of Apai-sa-le recipe and its ingredients.[Pubmed:25518295]
J Med Assoc Thai. 2014 Aug;97 Suppl 8:S64-9.
BACKGROUND: Acetylcholinesterase and butyrylcholoinesterase inhibitors are well-known drugs commonly used in the treatment ofAlzheimer's disease (AD) to improve cognitive function. These enzyme inhibitors were reported to be found in manyplants. Apai-sa-le recipe was a Thai tradition used as nootropic recipe and formerly claimed to improve memory. Therefore, it is interesting to investigate cholinesterase inhibitory activity ofthe recipe and its ingredients. OBJECTIVE: To determine the whole recipe ofApai-sa-le and its ingredients for inhibitory effect on acetylcholinesterase (AChE) and human butyrylcholinesterase (BuChE) activities. MATERIAL AND METHOD: Thirty grams of each plant and 181 grams of the whole recipe were separately extracted by 95% ethanol, after filtered the filtrate were evaporated and vacuum-dried at 45 degrees C. By Elman method, the inhibitory activities of both enzymes were assessed. The volatile constituents ofeach extract were determined by GCMS. The constituents in the non- volatile extract were examined by TLC and the antioxidant activity was determined. RESULTS: Four plants exhibited specific BuChE inhibitor were Lepidium sativum Linn. (Ls), Piper nigrum L. (Pn), Angelica dahurica Benth (Ad) andAtractylodes lancea DC. (Al), which shown the lC50 of 5.59, 24.52, 73.23, 96.25 mug/ml, respectively whereas galantamine and the whole recipe showed IC50 of 0.59 and 236 mug/ml. Only Pn extract inhibited AChE at lCso of 25.46 mug/ml. By GCMS and TLC fingerprints revealed the main constituents in LS, Ad, Al andPn as apiol, cumialdehyde, Furanodiene and piperine. Moreover nine plant extracts and the whole recipe showed antioxidant activity. CONCLUSION: Lepidium sativum Linn. (Ls) extract showed the most potency on BuChE inhibitory effect. Three ingredients and the whole recipe exhibited mild activity. Only Piper nigrum L demonstrated inhibition effect on both AChE and BuChE.
Therapeutic switching: from antidermatophytic essential oils to new leishmanicidal products.[Pubmed:25742270]
Mem Inst Oswaldo Cruz. 2015 Feb;110(1):106-13.
This study examined whether the antidermatophytic activity of essential oils (EOs) can be used as an indicator for the discovery of active natural products against Leishmania amazonensis. The aerial parts of seven plants were hydrodistilled. Using broth microdilution techniques, the obtained EOs were tested against three strains of dermatophytes (Trichophyton mentagrophytes, Microsporum gypseum and Microsporum canis). To compare the EOs antifungal and antiparasitic effects, the EOs activities against axenic amastigotes of L. amazonensis were concurrently evaluated. For the most promising EOs, their antileishmanial activities against parasites infecting peritoneal macrophages of BALB/c mice were measured. The most interesting antifungal candidates were the EOs from Cymbopogon citratus, Otacanthus azureus and Protium heptaphyllum, whereas O. azureus, Piper hispidum and P. heptaphyllum EOs exhibited the lowest 50% inhibitory concentration (IC50) values against axenic amastigotes, thus revealing a certain correspondence between both activities. The P. hispidum EO was identified as the most promising product in the results from the infected macrophages model (IC50: 4.7 microg/mL, safety index: 8). The most abundant compounds found in this EO were sesquiterpenes, notably curzerene and Furanodiene. Eventually, the evaluation of the antidermatophytic activity of EOs appears to be an efficient method for identifying new potential drugs for the treatment of L. amazonensis.
Furanodiene presents synergistic anti-proliferative activity with paclitaxel via altering cell cycle and integrin signaling in 95-D lung cancer cells.[Pubmed:23554049]
Phytother Res. 2014 Feb;28(2):296-9.
Furanodiene (FUR) is a natural terpenoid isolated from Rhizoma Curcumae, a well-known Chinese medicinal herb that presents anti-proliferative activities in several cancer cell lines. Recently, we found that the combined treatment of FUR with paclitaxel (TAX) showed synergetic anti-proliferative activities in 95-D lung cancer cells. Herein, we showed that FUR reduced the cell numbers distributed in mitosis phase induced by TAX while increased those in G1 phase. The protein levels of cyclin D1, cyclin B1, CDK6 and c-Myc were all down-regulated in the group of combined treatment. The dramatically down-regulated expression of integrin beta4, focal adhesion kinase and paxillin might partially contribute to the synergic effect. Though FUR alone obviously induced endoplasmic reticulum stress, this signaling pathway may not contribute to the synergetic anti-proliferative effect as the protein expression of CHOP and BIP was similar in FUR alone and combined treatment group.